Stock listing
NASDAQ:PFSA Profusa, Inc. Stock
Home listing (NASDAQ) of Profusa, Inc.
Follow Profusa, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:PFSA
$0.323 USD -0.031 (-8.7%)
Close on Nov 20, 2026
- Day range
- $0.310 – $0.349 USDNov 20, 2026
- Volume
- 162,965 sharesNov 20, 2026
- Market cap
- $195,866 USDAt the close on Nov 20, 2026 · price × 605,647 shares outstanding
- 52-week range
- $0.310 – $378.750 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $5.95M USDMedian day 276,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PFSA · Home | $0.323 USD | -0.031 (-8.7%) | 162,965 | $0.335 | $0.349 | $0.310 | $0.354 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PFSA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.323 | -0.031 | -8.7% | $0.335 | $0.349 | $0.310 | 162,965 | |
| $0.354 | +0.006 | +1.8% | $0.368 | $0.376 | $0.328 | 2,305,956 | |
| $0.348 | -0.058 | -14.2% | $0.383 | $0.386 | $0.323 | 221,086 | |
| $0.406 | -0.042 | -9.4% | $0.429 | $0.442 | $0.401 | 111,628 | |
| $0.448 | -0.012 | -2.6% | $0.487 | $0.487 | $0.412 | 406,374 | |
| $0.460 | -0.090 | -16.4% | $0.478 | $0.539 | $0.422 | 5,024,319 | |
| $0.550 | +0.001 | +0.2% | $0.540 | $0.650 | $0.533 | 700,412 | |
| $0.549 | -0.001 | -0.1% | $0.539 | $0.589 | $0.535 | 144,649 | |
| $0.550 | +0.015 | +2.9% | $0.537 | $0.551 | $0.528 | 42,495 | |
| $0.534 | -0.035 | -6.2% | $0.518 | $0.551 | $0.510 | 248,316 | |
| $0.570 | -0.047 | -7.7% | $0.611 | $0.615 | $0.540 | 122,730 | |
| $0.617 | -0.001 | -0.2% | $0.646 | $0.650 | $0.573 | 214,548 | |
| $0.618 | -0.033 | -5.0% | $0.625 | $0.670 | $0.609 | 280,159 | |
| $0.651 | -0.049 | -7.0% | $0.732 | $0.745 | $0.620 | 179,195 | |
| $0.700 | -0.071 | -9.2% | $0.775 | $0.775 | $0.686 | 160,359 | |
| $0.771 | +0.005 | +0.7% | $0.750 | $0.780 | $0.710 | 182,527 | |
| $0.766 | -0.014 | -1.8% | $0.759 | $0.779 | $0.700 | 257,565 | |
| $0.780 | 0.000 | 0.0% | $0.765 | $0.790 | $0.720 | 292,723 | |
| $0.780 | -0.059 | -7.1% | $0.770 | $0.815 | $0.737 | 386,929 | |
| $0.839 | -0.181 | -17.7% | $1.060 | $1.080 | $0.821 | 1,127,271 | |
| $1.020 | +0.171 | +20.1% | $1.040 | $1.350 | $0.900 | 44,829,279 | |
| $0.849 | -0.036 | -4.0% | $0.864 | $0.864 | $0.700 | 214,513 | |
| $0.885 | -0.015 | -1.7% | $0.889 | $0.902 | $0.825 | 140,287 | |
| $0.900 | -0.031 | -3.3% | $0.932 | $0.940 | $0.880 | 110,415 | |
| $0.931 | -0.139 | -13.0% | $1.020 | $1.027 | $0.931 | 143,011 | |
| $1.070 | -0.210 | -16.4% | $1.060 | $1.080 | $0.910 | 3,468,303 | |
| $1.280 | 0.000 | 0.0% | $1.250 | $1.450 | $1.180 | 629,388 | |
| $1.280 | -0.020 | -1.5% | $1.280 | $1.310 | $1.230 | 98,700 | |
| $1.300 | -0.120 | -8.5% | $1.360 | $1.403 | $1.250 | 264,800 | |
| $1.420 | -0.070 | -4.7% | $1.420 | $1.530 | $1.400 | 232,700 | |
| $1.490 | -0.010 | -0.7% | $1.530 | $1.650 | $1.450 | 819,000 | |
| $1.500 | -0.160 | -9.6% | $1.620 | $1.680 | $1.420 | 424,200 | |
| $1.660 | -0.090 | -5.1% | $1.720 | $1.729 | $1.600 | 261,600 | |
| $1.750 | +0.060 | +3.6% | $1.710 | $1.760 | $1.610 | 276,500 | |
| $1.690 | -0.180 | -9.6% | $1.830 | $1.833 | $1.670 | 363,100 | |
| $1.870 | -0.110 | -5.6% | $1.900 | $1.950 | $1.700 | 574,100 | |
| $1.980 | -0.290 | -12.8% | $1.990 | $2.290 | $1.881 | 1,263,400 | |
| $2.270 | +0.580 | +34.3% | $1.660 | $2.450 | $1.631 | 10,946,100 | |
| $1.690 | -0.490 | -22.5% | $1.980 | $2.020 | $1.690 | 824,900 | |
| $2.180 | -0.850 | -28.1% | $2.700 | $2.750 | $2.100 | 2,544,900 | |
| $3.030 | +0.980 | +47.8% | $3.510 | $4.180 | $2.390 | 79,266,600 | |
| $2.050 | -0.120 | -5.5% | $1.880 | $2.380 | $1.862 | 1,856,500 | |
| $2.170 | +0.230 | +11.9% | $1.890 | $2.230 | $1.850 | 4,049,600 | |
| $1.940 | +0.030 | +1.6% | $1.870 | $2.000 | $1.821 | 54,700 | |
| $1.910 | +0.110 | +6.1% | $1.820 | $2.100 | $1.810 | 197,700 | |
| $1.800 | +0.020 | +1.1% | $1.720 | $1.820 | $1.580 | 138,600 | |
| $1.780 | -0.050 | -2.7% | $1.860 | $2.279 | $1.700 | 794,500 | |
| $1.830 | -0.760 | -29.3% | $2.350 | $2.400 | $1.770 | 1,130,500 | |
| $2.590 | +0.160 | +6.6% | $2.450 | $2.670 | $2.380 | 107,900 | |
| $2.430 | -0.070 | -2.8% | $2.430 | $2.656 | $2.350 | 77,800 | |
| $2.500 | +0.030 | +1.2% | $2.520 | $2.650 | $2.370 | 199,700 | |
| $2.470 | -0.410 | -14.2% | $2.870 | $2.870 | $2.420 | 171,100 | |
| $2.880 | +0.160 | +5.9% | $2.920 | $2.980 | $2.770 | 191,600 | |
| $2.720 | +0.100 | +3.8% | $2.550 | $2.870 | $2.550 | 165,900 | |
| $2.620 | -0.050 | -1.9% | $2.660 | $2.660 | $2.490 | 146,300 | |
| $2.670 | -0.210 | -7.3% | $2.880 | $2.895 | $2.560 | 201,800 | |
| $2.880 | -0.120 | -4.0% | $2.980 | $2.980 | $2.740 | 221,200 | |
| $3.000 | +0.070 | +2.4% | $3.100 | $3.550 | $2.840 | 1,228,300 | |
| $2.930 | -1.310 | -30.9% | $4.100 | $4.130 | $2.740 | 635,000 | |
| $4.240 | -0.015 | -0.4% | $4.230 | $4.760 | $4.100 | 345,500 | |
| $4.255 | -0.745 | -14.9% | $4.490 | $4.501 | $4.110 | 283,700 | |
| $5.000 | +0.420 | +9.2% | $4.450 | $5.180 | $3.920 | 1,278,600 | |
| $4.580 | -0.880 | -16.1% | $5.260 | $5.687 | $4.250 | 469,000 | |
| $5.460 | -2.110 | -27.9% | $6.650 | $7.537 | $5.280 | 647,700 | |
| $7.570 | -6.000 | -44.2% | $12.920 | $13.000 | $7.110 | 1,180,200 |
Splits
3 splits since 2026 · NASDAQ:PFSA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-4 | Consolidation | |
| 1-for-25 | Consolidation | |
| 1-for-75 | Consolidation |
- Ticker
- NASDAQ:PFSA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
Latest news
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
Nov 12, 2026
Closed $0.46 (-16.4%) on Nov 12, 2026
Profusa Receives ISO 13485: 2016 Certificate from GMED
Oct 15, 2026
Closed $1.07 (-16.4%) on Oct 15, 2026
Profusa, Inc. Receives Nasdaq Compliance Determination
Sep 15, 2026
Closed $1.83 (-29.3%) on Sep 15, 2026
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
Aug 31, 2026
Closed $3.00 (+2.4%) on Aug 31, 2026
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
Aug 20, 2026
Closed $7.57 (-44.2%) on Aug 20, 2026
Profusa Announces 1-for-4 Reverse Stock Split
Aug 13, 2026
Closed $3.80 (-1.5%) on Aug 13, 2026
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
Jul 31, 2026
Closed $0.963 (-9.1%) on Aug 3, 2026
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
Jul 27, 2026
Closed $1.22 (-28.7%) on Jul 27, 2026
Profusa Announces 1-for-25 Reverse Stock Split
Jul 2, 2026
Closed $2.35 (-27.7%) on Jul 2, 2026
Profusa, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 28 in the last 12 months · 41 in all · newest Nov 12, 2026 · oldest 2025
- Decks
- 7 decks · latest Oct 30, 2025
Where Profusa, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PFSA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PFSA | BOATS | United States | USD |
Valuation
Price/book 0.0× against a median of 1.3×: the lowest of 5 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$8.20M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.0×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.99
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Profusa, Inc. · NASDAQ:PFSA | US$195,866 | −US$8.20M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.99 |
| Therma Bright Inc. · TSXV:THRM | US$1.66M | US$1.64M | n/a | 17.3× | n/a | n/a | n/a | n/a | -0.15 |
| Nexalin Technology, Inc. · NASDAQ:NXL | US$1.45M | US$1.88M | n/a | 6.8× | n/a | 5.5× | n/a | 4.7× | 0.52 |
| Zero Candida Technologies Inc. · TSXV:ZCT | US$1.43M | −US$59,297 | n/a | n/a | n/a | 2.2× | n/a | 0.0× | -0.17 |
| Osteopore Ltd. · ASX:OSX | US$1.38M | US$596,079 | n/a | 0.3× | n/a | n/a | −121.8% | n/a | n/a |
| SpectraCure AB · OMXSTO:SPEC | US$978,306 | US$1.10M | n/a | 32.1× | n/a | 0.1× | n/a | 0.1× | n/a |
| Odyssey Health Inc. · OTC:ODYY | US$716,421 | US$594,060 | n/a | n/a | n/a | n/a | n/a | n/a | 0.58 |
| S2Medical AB Class B · OMXSTO:S2M | US$355,391 | US$300,229 | n/a | 0.2× | n/a | 0.4× | −62.1% | 0.0× | n/a |
| Imaging Dynamics Company, Ltd. · TSXV:IDL | US$252,238 | US$243,907 | n/a | 8.8× | n/a | n/a | n/a | n/a | -0.28 |
| Sigyn Therapeutics, Inc. · OTC:SIGY | US$161,983 | US$3.93M | n/a | n/a | n/a | n/a | n/a | n/a | 1.70 |
| Safe SA · EURONEXT:ALSAF | US$139,941 | US$14.53M | n/a | 2.5× | n/a | n/a | −75.9% | n/a | n/a |
| Median of the others | US$847,364 | US$849,836 | 6.8× | 1.3× | −75.9% | 0.1× | 0.19 |
Team and board
Officers
| Officer | Role |
|---|---|
| Ben Hwang | Chairman and Chief Executive Officer |
| Fred Knechtel | Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Ben Hwang | Chairman and Chief Executive Officer |
| Jack Stover | Director |
| Lauren Chung | Director |
| Peter O’Rourke | Lead Independent Director |
| Rajesh Asorpota | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 13, 2026 | −11.8% |
| Q2 2026 | Aug 19, 2026 | −72.5% |
| Q3 2025 | Nov 19, 2025 | −24.4% |
| Q2 2025 | Aug 22, 2025 | +5.2% |
| Q1 2025 | Jun 27, 2025 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2025) | Investor deck | 22 slides | Oct 30, 2025 |
| Investor Presentation (October 2025) | Investor deck | 22 slides | Oct 21, 2025 |
| NorthView Acquisition — SPAC Merger (April 2024) | SPAC merger | 29 slides | Apr 8, 2024 |
| NorthView Acquisition — SPAC Merger (January 2024) | SPAC merger | 29 slides | Jan 29, 2024 |
| NorthView Acquisition — SPAC Merger (March 2023) | SPAC merger | 35 slides | Mar 2, 2023 |
| SPAC Merger (November 2022) | SPAC merger | 37 slides | Nov 10, 2022 |
| Conference Presentation (November 2016) | Conference | 33 slides | November 2016 |
Financings
| Raise | Date |
|---|---|
| Note Tranche closed: US$700,000 raised Buyers: Ascent Partners (lent $0.7 million in October under the current note agreement) Use of proceeds: Near-term working capital needs | Nov 12, 2026 |
| Public offering of securities under Registration Statement on Form S-1 (No. 333-293451) Cancelled: US$15M | Feb 27, 2026 |
| Senior Secured Convertible Notes Closed: US$9M raised Use of proceeds: To cover transaction costs and support future working capital needs | Dec 30, 2025 |
| Additional investments (second tranche) Tranche closed: US$2M raised Buyers: Ascent Partners Fund (funded the second tranche of $2 million in additional investments) Use of proceeds: Bitcoin digital treasury strategy | Oct 7, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Went public as NorthView Acquisition Corp, a blank check company (SPAC). Priced at US$10.00 a unit on Dec 20, 2021.
- Price
- US$10.00 a unit
- Units offered
- 16,500,000 units
- Offering size
- US$165 million
- Underwriters' option
- Up to 2,475,000 more units
- Listing
- NVACU on the Nasdaq Global Market
- Underwriters
- I-Bankers Securities, Inc., Dawson James Securities, Inc. · In the order on the cover
- Units delivered
- On or about Dec 22, 2021
Steps
| Step | When |
|---|---|
| Filed publicly | Jun 17, 2021 |
| Amended 3 times | Newest Dec 14, 2021 |
| Shares registered with an exchange | Dec 16, 2021 |
| Declared effective by the SEC | Dec 20, 2021 |
| Final prospectus, with the price | Dec 22, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Dec 22, 2021 |
| EFFECT · Notice that a registration is effective | Dec 20, 2021 |
| S-1MEF · Registration of more shares for the same offering | Dec 20, 2021 |
| CORRESP · Letter to the SEC | Dec 17, 2021 |
| CORRESP · Letter to the SEC | Dec 17, 2021 |
| CORRESP · Letter to the SEC | Dec 17, 2021 |
| CORRESP · Letter to the SEC | Dec 17, 2021 |
| CERT · Exchange's certificate of listing | Dec 17, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 16, 2021 |
| CORRESP · Letter to the SEC | Dec 15, 2021 |
All 19 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Dec 15, 2021 |
| S-1/A · Registration statement, amended | Dec 14, 2021 |
| S-1/A · Registration statement, amended | Dec 7, 2021 |
| CORRESP · Letter to the SEC | Dec 6, 2021 |
| UPLOAD · Letter from the SEC | Sep 22, 2021 |
| CORRESP · Letter to the SEC | Aug 19, 2021 |
| UPLOAD · Letter from the SEC | Jul 26, 2021 |
| S-1/A · Registration statement, amended | Jul 1, 2021 |
| S-1 · Registration statement | Jun 17, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Dec 22, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 100.0K | |||
| Research and development | 2.80M | 1.61M | ||
| Operating income | -27.7M | -4.50M | -1.51M | -1.27M |
| Interest expense | 2.52M | 4.42M | ||
| Income before tax | -8.63M | 1.62M | 7.67M | |
| Income tax | 80.5K | 456.8K | 499.2K | |
| Net income | -35.8M | -9.23M | 1.16M | 7.17M |
| Earnings per share, basic | -107.01 | -357.14 | 0.12 | 0.30 |
| Earnings per share, diluted | -107.01 | -357.14 | 0.12 | 0.30 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 1.78M | 191.0K | 4.52K | 193.5K |
| Current assets | 3.76M | 260.0K | 1.58M | 511.7K |
| Property, plant and equipment | 8.00K | |||
| Total assets | 3.77M | 3.07M | 10.9M | 194.7M |
| Accounts payable | 7.34M | 4.95M | ||
| Current liabilities | 22.3M | 57.1M | 4.92M | 935.8K |
| Total liabilities | 30.4M | 57.1M | 5.09M | 1.83M |
| Shareholders' equity | -26.7M | -119.2M | -110.0M | -619.5K |
| Shares outstanding | 12.3K | 25.8K | 5.19M | 5.19M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -16.2M | -2.07M | -2.06M | -581.2K |
| Capital spending | -8.00K | |||
| Free cash flow | -16.3M | |||
| Cash from investing | -2.01M | 2.97M | 185.6M | 33.4K |
| Cash from financing | 19.8M | 2.12M | -183.7M | |
| Share buybacks | -3.25M | -184.8M | ||
| Change in cash | 1.59M | 49.0K | -189.0K | -547.7K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 13, 2026 | Quarterly report | SEC |
| PRE 14A · Preliminary proxy statement | Nov 10, 2026 | Meeting notice | SEC |
| 8-K · Current report | Nov 6, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 27, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Oct 15, 2026 | Material contract | SEC |
| 8-K · Current report | Oct 9, 2026 | Current report | SEC |
| 8-K · Current report | Oct 5, 2026 | Material contract | SEC |
| 8-K · Current report | Sep 18, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Sep 16, 2026 | Material contract | SEC |
| 8-K · Current report | Sep 15, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Sep 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 1, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 31, 2026 | Current report | SEC |
| DEF 14A · Proxy statement | Aug 28, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 21, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 20, 2026 | Results | SEC |
| 4 · Change in ownership | Aug 19, 2026 | Insider trade | SEC |
| SCHEDULE 13D · Big-stake notice | Aug 19, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 19, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 19, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 19, 2026 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Aug 18, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2026 | Explanation request | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 13, 2026 | Current report | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 4, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 3, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 31, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jul 30, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 30, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 27, 2026 | Management or board change | SEC |
| 424B3 · Prospectus | Jul 7, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Jul 7, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Jul 7, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Jul 7, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Jul 7, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 6, 2026 | Current report | SEC |
| 8-K · Current report | Jun 23, 2026 | Meeting outcome | SEC |
| 424B3 · Prospectus | Jun 8, 2026 | Offer document | SEC |
| 8-K · Current report | Jun 8, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jun 5, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | May 26, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | May 26, 2026 | Meeting notice | SEC |
| 8-K · Current report | May 26, 2026 | Material contract | SEC |
| 424B3 · Prospectus | May 18, 2026 | Offer document | SEC |
| 8-K · Current report | May 18, 2026 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 15, 2026 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | May 12, 2026 | Meeting notice | SEC |
| 8-K · Current report | May 8, 2026 | Current report | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | May 5, 2026 | Other filings | SEC |
| 424B3 · Prospectus | May 4, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | May 1, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 1, 2026 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Apr 30, 2026 | Other filings | SEC |
| 8-K · Current report | Apr 29, 2026 | Material contract | SEC |
| S-1 · Registration statement | Apr 28, 2026 | Offer document | SEC |
| 8-K · Current report | Apr 27, 2026 | Material contract | SEC |
| 8-K · Current report | Apr 24, 2026 | Material contract | SEC |
| 10-K · Annual report | Apr 15, 2026 | Annual report | SEC |
| 8-K · Current report | Apr 6, 2026 | Material contract | SEC |
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| 8-K · Current report | Mar 26, 2026 | Material contract | SEC |
| 8-K · Current report | Mar 12, 2026 | Acquisition or disposal | SEC |
| EFFECT · Notice that a registration is effective | Mar 4, 2026 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Mar 2, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Feb 18, 2026 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Feb 18, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Feb 17, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 17, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 17, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 13, 2026 | Material contract | SEC |
| CORRESP · Letter to the SEC | Feb 13, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 13, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 13, 2026 | Offer document | SEC |
| S-1 · Registration statement | Feb 13, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Feb 10, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Feb 10, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Feb 10, 2026 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Feb 10, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 9, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Feb 5, 2026 | Current report | SEC |
| S-1 · Registration statement | Feb 3, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 2, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Feb 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 29, 2026 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Jan 29, 2026 | Other filings | SEC |
| DRS · Draft registration statement | Jan 28, 2026 | Offer document | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| DEF 14A · Proxy statement | Jan 2, 2026 | Meeting notice | SEC |
| 8-K · Current report | Dec 30, 2025 | Material contract | SEC |
| 424B3 · Prospectus | Dec 23, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 23, 2025 | Material contract | SEC |
| PRE 14A · Preliminary proxy statement | Dec 19, 2025 | Meeting notice | SEC |
| 8-K · Current report | Nov 19, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Nov 19, 2025 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 14, 2025 | Explanation request | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 13, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 31, 2025 | Current report | SEC |
| 8-K · Current report | Oct 30, 2025 | Current report | SEC |
| 424B3 · Prospectus | Oct 28, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 20, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Oct 20, 2025 | Current report | SEC |
| S-1 · Registration statement | Oct 9, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 7, 2025 | Material contract | SEC |
| DEFA14A · Additional proxy material | Oct 7, 2025 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Sep 29, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Sep 26, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Sep 24, 2025 | Other filings | SEC |
| DEF 14A · Proxy statement | Sep 23, 2025 | Meeting notice | SEC |
| CORRESP · Letter to the SEC | Sep 16, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Sep 16, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 16, 2025 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Sep 10, 2025 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | Sep 9, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 4, 2025 | Meeting outcome | SEC |
| S-1 · Registration statement | Aug 29, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Aug 26, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 25, 2025 | Material contract | SEC |
| 424B3 · Prospectus | Aug 25, 2025 | Offer document | SEC |
| S-1/A · Registration statement, amended | Aug 22, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Aug 21, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 21, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 19, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Aug 18, 2025 | Other filings | SEC |
| DEF 14A · Proxy statement | Aug 18, 2025 | Meeting notice | SEC |
| 8-K/A · Current report, amended | Aug 14, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| S-1 · Registration statement | Aug 8, 2025 | Offer document | SEC |
| PRE 14A · Preliminary proxy statement | Aug 8, 2025 | Meeting notice | SEC |
| 8-K · Current report | Aug 7, 2025 | Current report | SEC |
| 8-K · Current report | Jul 28, 2025 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 24, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jul 22, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 18, 2025 | Acquisition or disposal | SEC |
| DEF 14C | Jul 14, 2025 | Meeting notice | SEC |
| CERT · Exchange's certificate of listing | Jul 11, 2025 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Jul 11, 2025 | Other filings | SEC |
| 8-K · Current report | Jul 3, 2025 | Current report | SEC |
| PRE 14C | Jul 2, 2025 | Meeting notice | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Jun 18, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Jun 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jun 13, 2025 | Management or board change | SEC |
| 425 | Jun 9, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 9, 2025 | Current report | SEC |
| 25-NSE | May 22, 2025 | Other filings | SEC |
| NT 10-Q · Late filing notice | May 16, 2025 | Explanation request | SEC |
| SEC STAFF LETTER | May 16, 2025 | Other filings | SEC |
| 424B3 · Prospectus | May 15, 2025 | Offer document | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | May 15, 2025 | Other filings | SEC |
| 425 | May 14, 2025 | Other filings | SEC |
| 8-K · Current report | May 14, 2025 | Material contract | SEC |
| CORRESP · Letter to the SEC | May 13, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 12, 2025 | Other filings | SEC |
| S-4/A · Registration statement, amended | May 12, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | May 12, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 8, 2025 | Other filings | SEC |
| S-4/A · Registration statement, amended | May 8, 2025 | Offer document | SEC |
| 8-K · Current report | May 2, 2025 | Current report | SEC |
| CORRESP · Letter to the SEC | Apr 25, 2025 | Other filings | SEC |
| S-4/A · Registration statement, amended | Apr 25, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Apr 18, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Apr 3, 2025 | Other filings | SEC |
| S-4/A · Registration statement, amended | Apr 3, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 28, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 25, 2025 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Mar 18, 2025 | Meeting notice | SEC |
| 8-K · Current report | Mar 18, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Mar 7, 2025 | Other filings | SEC |
| DEF 14A · Proxy statement | Mar 6, 2025 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | Feb 28, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 27, 2025 | Other filings | SEC |
| PRER14A | Feb 27, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 26, 2025 | Other filings | SEC |
| 425 | Feb 18, 2025 | Other filings | SEC |
| 8-K · Current report | Feb 18, 2025 | Material contract | SEC |
| PRE 14A · Preliminary proxy statement | Feb 18, 2025 | Meeting notice | SEC |
| S-4/A · Registration statement, amended | Feb 12, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 11, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 26, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Dec 17, 2024 | Quarterly report | SEC |
| 8-K · Current report | Dec 11, 2024 | Current report | SEC |
| NT 10-Q · Late filing notice | Nov 15, 2024 | Explanation request | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 18, 2024 | Current report | SEC |
This page holds 200 of 326 filings. Open Filings
Cap table
Built by 6ix from Profusa, Inc.’s releases · as of Nov 12, 2026
- Common shares
- 605,647
- Fully diluted
- 605,647
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 605,647 | Aug 18, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 18, 2026 | 605,647 |
| Aug 13, 2026 | |
| Jul 2, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jack E Stover Other companies: TransCode Therapeutics, Inc. (Director · Since at least Dec 19, 2025); Traws Pharma, Inc. (Director · Since at least May 18, 2016); PharmaCyte Biotech, Inc. (Director · Aug 15, 2022 – Aug 15, 2022 · Past); Antares Pharma Inc (President and CEO, Director · Jan 25, 2006 – May 14, 2008 · Past); Interpace Biosciences, Inc. (President and CEO, Director · Aug 3, 2005 – Mar 12, 2020 · Past) | Chief Executive Officer · Since at least Dec 20, 2021 |
| Jack E. Stover Other companies: TransCode Therapeutics, Inc. (Director · Since at least Dec 22, 2025) | Director · Since at least Aug 20, 2026 |
| Lauren Chung Other companies: Aditxt, Inc. (Director · Jun 16, 2021 – Jul 14, 2021 · Past) | Director · Since at least Dec 20, 2021 |
| Rajesh Asarpota Other companies: Maravai LifeSciences Holdings, Inc. (Chief Financial Officer · Since at least Jun 30, 2025) | Director · Since at least Jul 11, 2025 |
| Ben Chung-Bin Hwang | Chief Executive Officer, Director · Since at least Jul 11, 2025 |
| Ben C. Hwang | Chairman and Chief Executive Officer · Since at least Jun 10, 2026 |
| Fred Knechtel | Chief Financial Officer · Since at least Aug 19, 2025 |
| Fred S Knechtel | Chief Financial Officer · Since at least Jan 26, 2026 |
| Peter O’Rourke | Lead Independent Director · Since at least Aug 19, 2025 |
| Rajesh Asorpota | Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Profusa, Inc.